C18-PEG4-N3, PEG MW 176 Da
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | C18-PEG-N3 |
| Catalog NO. | BPG-0392 |
| Product Name | C18-PEG4-N3, PEG MW 176 Da |
- Scheme Design
- Custom Synthesis
- cGMP Manufacturing
- Quality Assurance
- Product Information
- Documents
- Reviews
Product Information
| Description | The PEG derivatives of the C18-PEG(n) series also belong to monodisperse PEG. It is a linear PEG derivative with 18 linear carbon straight chains and a different reactive group at the other end that can modify peptides, proteins, lipids or small molecules. The azide group, can be used for click reaction and chemistry with alkyne or acetylene. As a drug crosslinker, it is widely used in medical research. Drug PEG modification can alter its dispersion and solubility in aqueous solutions. PEG modification can create a spatial barrier around the drug, reduce the enzymatic hydrolysis of the drug, avoid the rapid elimination of kidney metabolism, and allow the drug to be recognized by cells of the immune system. |
| Synonyms | Tetraethylene glycol octadecyl ether azide |
| Solubility | Soluble in water, DMSO and DMF. Freshly prepared before use. |
| Storage | -20°C for long-term preservation, keep in dry and avoid sunlight. Avoid repeated freezing and thawing. |
Reviews
If you have any suggestions or comments about C18-PEG4-N3, PEG MW 176 Da , please submit a review immediately.
Why BOC Sciences?
-
Large Stock
More than 2000+ products in inventory
-
Global Delivery
Warehouses in multiple cities to ensure fast delivery
-
mg to kg
Multi specification for academic research and industrial production
-
24/7 Technical Support
Strict process parameter control to ensure product quality
Our Feature
BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.
PEGylation of Peptides
and Proteins
Reduce the Immunogenicity of Peptide/Protein Drugs
Learn More
APPLICATIONS
PEG linkers For Drug
Improved Circulation Half-Life
Learn More
Have Customer
Reviewed On Us?
Chat With Us
